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Background: The RNA binding protein Hfq of Haemophilus influenzae is highly homologous to Hfq from other
bacterial species. In many of these other bacteria, Hfq affects the expression of a broad range of genes and
enhances the ability to respond to stressful environments. However, the role of Hfq in H. influenzae is unknown.
Results: Deletion mutants of hfq were generated in the nontypeable H. influenzae strains R2866 and 86-028NP to
assess the role of Hfq in these well characterized but genotypically and phenotypically divergent clinical isolates.
A deletion mutation of hfq had no effect on growth of H. influenzae in nutrient rich media and had no effect on
survival in several stressful conditions in vitro. However, the mutation resulted in a reduced ability to utilize heme
from hemoglobin. The mutant and wild type strains were assessed for virulence and competitive fitness in models
of invasive disease and otitis media. In the chinchilla model of otitis media, the hfq mutant of 86-028NP exhibited
impaired competitive fitness when compared to its wild type progenitor but exhibited no apparent defect in
virulence. In the infant rat model, deletion of hfq in R2866 resulted in reduced bacterial titers in blood and a shorter
duration of infection when compared to the wild type strain in the competitive fitness study.
Conclusion: We conclude that Hfq is involved in the utilization of essential nutrients and facilitates infection by
H. influenzae.
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H. influenzae is a fastidious, Gram-negative, opportunis-
tic pathogen that belongs to the family Pasteurellaceae
and is a common commensal in the nasopharynx of
humans [1,2]. H. influenzae is a causative agent of both
invasive and non-invasive diseases including bacteremia,
meningitis, respiratory infections, and otitis media [1].
Invasive disease may be caused by either encapsulated or
nonencapsulated strains [3], whereas non-invasive diseases
are primarily caused by nonencapsulated, nontypeable
H. influenzae [4].
Like most other bacteria, H. influenzae requires iron
for growth but it also has an absolute requirement for a
porphyrin source, in the form of protoporphyrin IX
(PPIX) or heme, to grow aerobically [5]. This requirement
for a porphyrin source is due to the lack of enzymes* Correspondence: tstull@ouhsc.edu
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reproduction in any medium, provided the orrequired to synthesize the protoporphyrin ring. Therefore,
H. influenzae must acquire heme from host sources in
order to establish and sustain an infection [6]. Potential
sources of heme in the human host are limited; heme
is generally intracellular, bound by hemoglobin or
other heme-containing proteins, and there is no significant
source of PPIX [7,8]. H. influenzae has evolved multiple
mechanisms to counter and exploit host mechanisms
for sequestering heme from invading pathogens [9].
Although many of these mechanisms are transcriptionally
upregulated in response to iron and heme restriction, the
specific regulation of many of these systems is largely
uncharacterized in H. influenzae [10,11].
The RNA-binding protein Hfq is an important regula-
tor of gene transcription, including the transcription of
iron responsive genes, in many bacterial pathogens such
as Escherichia coli, Neisseria meningitidis, and Salmo-
nella enterica [12-14]. The Hfq protein was originally
described as a host factor required for the synthesis of
bacteriophage Qβ RNA in E. coli and belongs to the Sm
and Sm-like family of proteins that are found in bothl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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scribed as an integral component of post-transcriptional
gene regulation because of its ability to bind both small
regulatory RNAs (sRNAs) and their mRNA target, altering
the stability of the bound mRNA [17]. Several studies have
revealed the role of Hfq and sRNAs in post-transcriptional
regulation of iron responsive genes [18-20]. Hfq is found in
many bacterial pathogens and is a pleiotropic gene regula-
tor; mutants exhibit phenotypes including defects in viru-
lence, growth rates, stress tolerance and biofilm formation
[21]. The phenotypes of hfq mutants vary greatly between
bacterial species because of the wide array of RNA with
which Hfq interacts [17].
Here we report the characterization of a deletion mu-
tant of hfq in H. influenzae. We demonstrate in vitro
that Hfq is important in modulating the utilization of
heme from hemoglobin. Further we show that Hfq plays
a role in pathogenesis in the infant rat and chinchilla
models of disease. Thus, Hfq may be modulating nutri-
ent utilization systems that allow H. influenzae to better
adapt to niches within the host during infection.
Methods
Bacterial strains and growth conditions
Nontypeable H. influenzae strain R2866 is a clinical iso-
late from the blood of an immunocompetent pediatric
patient with clinical signs of meningitis following acute
OM [22]. Nontypeable H. influenzae strain 86-028NP
was isolated from the nasopharynx of a child being
treated for chronic OM who underwent tympanostomy
and tube insertion [23,24]. H. influenzae strains were
routinely grown on chocolate agar with bacitracin at
37°C. H. influenzae was also cultured on brain heart in-
fusion (BHI) agar or in BHI broth supplemented with
10 μg mL-1 heme and 10 μg mL-1 β-NAD (supplemented
BHI; sBHI) or BHI supplemented with 10 μg mL-1 β-NAD
(heme deplete BHI; hdBHI). The antibiotics spectinomycin
(200 μg mL-1) and chloramphenicol (2.0 μg mL-1) were
used when appropriate.
Heme sources
Human hemoglobin and heme (as hemin) were pur-
chased from Sigma. Stock heme solutions were prepared
at 1.0 mg mL-1 heme in 4% v/v triethanolamine as previ-
ously described [25]. Hemoglobin was dissolved in water
immediately before use.
Construction of the hfq mutant
A deletion mutant lacking the entire hfq gene was
constructed using two pairs of primers to amplify regions
upstream and downstream of hfq by PCR using strain
R2866 DNA as template. Primer pair Hfq_US1 (GAATT
CGATTTGTTAGGAAAGCCTGCC) and Hfq_US2 (GGA
TCCGCGGTTGAAAATTCTCAGGAAA) was used toamplify an 867-bp fragment upstream of hfq with
EcoRI and BamHI restriction sites engineered into
the primers, respectively, to allow for directional sub-
cloning. Hfq_DS1 (GGATCCAGAAACGAGTTGTCTC
CGTG) and Hfq_DS2 (AAGCTTCGAAGTGCGAGTA
AACAAAGGC) were used to amplify an 869-bp frag-
ment downstream of hfq with BamHI and HindIII re-
striction sites incorporated into the primers, respectively.
The PCR products were cloned into the TA cloning vec-
tor pCR2.1-TOPO (Invitrogen) and the cloned sequences
were confirmed by DNA sequencing. After the DNA se-
quences were confirmed, the upstream and downstream
fragments were directionally subcloned into pUC19N to
give a plasmid containing the fragments abutting each
other with a unique BamHI site between the two pro-
ducts. The BamHI site was used to insert a 1214-bp
fragment containing a spectinomycin resistance cas-
sette from pSPECR [26], and produced the mutagenic
construct pRH30.
The plasmid construct pRH30 was used to transform
H. influenzae strains R2866 and 86-028NP by the static-
aerobic method as previously described [27] and trans-
formants were selected on spectinomycin. Transformants
resistant to spectinomycin were confirmed using PCR.
Complementation of the hfq deletion mutant
For complementation of the hfq deletion a region
encompassing 450-bp upstream to 286-bp downstream
of hfq was amplified from strain R2866 using primers
Hfqcmp_fwd (GGATCCACAAAGTGCGGTGATTTCTT
TGGAT) and Hfqcmp_rev (TCTAGAGAATTATCTA
GCGGAGAGCGCATTG). The primers Hfqcmp_fwd and
Hfqcmp_rev had respectively BamHI and XbaI restriction
sites incorporated to allow for subcloning. The PCR prod-
uct was cloned into pCR2.1-TOPO and subsequently
subcloned into the vector pASK5 to yield pRH38. The vec-
tor pASK5 was designed to allow complementation of gene
disruptions in H. influenzae by insertion of a gene in the
nonessential outer-membrane protein OmpP1 locus and
has been successfully used in our laboratory [28-33]. The
plasmid pRH38 was used to transform the R2866 Δhfq
strain, HI2206, to chloramphenicol resistance to yield
strain HI2210. Correct insertion of the complementation
construct was confirmed by PCR.
Primer extension analysis
Primer extension analysis was performed as previously de-
scribed [34,35]. RNA was purified from a H. influenzae cul-
ture grown to mid-log phase in sBHI using the Qiagen
RNeasy Mini Kit. The RNA was DNase treated and the
integrity was verified by agarose gel electrophoresis. A
total of 10 μg of RNA was used to synthesize cDNA
using a 6-carboxyfluorescein (FAM)-labeled primer, hfq-PE
(ATTGATACAGGAATGCGTTCACGAC). The hfq-PE
Hempel et al. BMC Microbiology 2013, 13:134 Page 3 of 10
http://www.biomedcentral.com/1471-2180/13/134primer was added to the RNA and they were incubated
at 70°C for 10 min and chilled on ice before being incu-
bated at 65°C for 2 min. The mixture was incubated at
42°C and the cDNA synthesis reagents [4 μl 10× reverse
transcriptase (RT) buffer, 8 μL 25 mMMgCl2, 4 μL 10 mM
deoxynucleoside triphosphates (dNTPs), 1 μl RNase inhibi-
tor, 2 μL Multiscribe RT (Applied Biosystems)] were added
to the mixture, incubated for 2 h, and ethanol precipitated.
The sizing of the cDNA fragments was performed by
the Laboratory for Genomics and Bioinformatics at the
University of Oklahoma Health Sciences Center. Analysis
of the fragments was done using Peak Scanner software
(Applied Biosciences).
Growth studies with H. Influenzae
Growth studies were performed using the Bioscreen
C Microbiology Reader (Oy Growth Curves AB Ltd.,
Helsinki, Finland) as previously described [36,37]. H.
influenzae strains were grown for 16 hours on chocolate
agar with bacitracin and used to seed hdBHI broth cul-
tures which were incubated for 3 h with shaking at 37°C.
The 3 h cultures were pelleted by centrifugation, washed
in phosphate buffered saline (PBS) containing 0.1% w/v
gelatin, and resuspended to an optical density of 0.5
at 605 nm in the same buffer. The bacterial suspen-
sion was diluted by adding 1.0 mL into 5.0 mL of PBS
containing 0.1% gelatin and was used to inoculate media
for growth curves (approximate initial concentration of
200,000 cfu ml-1).
In vitro competition studies were performed by mixing
equal numbers of the wild type and mutant strains
(starting total of approximately 2 × 105 cfu ml-1) in
50 ml of either sBHI or hdBHI supplemented with limiting
concentrations of hemoglobin (5 μg ml-1. Bacterial counts
were determined for the duration of the 28 hour experi-
ment by plating samples using the track dilution method,
as previously described [38], on sBHI or sBHI containing
spectinomycin to allow enumeration of both strains.
Chinchilla model of otitis media
Adult chinchillas (Chinchilla lanigera) with no signs of
middle ear infection by either otoscopy or tympanometry
at the beginning of the study were used. Animals were
allowed to acclimate to the vivarium for at least 14 days
prior to transbullar challenge. Animal procedures have
been previously described in detail [39-41].
Two separate experiments, one to assess virulence and
a second to assess competitive fitness, were performed
in the chinchillas.
In the first experiment to compare virulence, two
groups of 5 animals were challenged in both ears by
transbullar injection with approximately 2,000 cfu of ei-
ther strain 86-028NP or its hfq deletion mutant HI2207.
Transbullar inocula were delivered in 300 μl 0.1% gelatinin PBS by direct injection into the superior bullae. Ac-
tual bacterial doses were confirmed by plate count. On
days 4, 7, 11, and 14 post-challenge middle ear effusions
(MEE) were collected by epitympanic tap as previously
described [29]. Bacterial titers in recovered MEE were
determined using the track dilution method.
In the second experiment, to assess competitive fitness,
five animals were challenged in both ears transbullarly
with a mixture containing equal numbers of 86-028NP
and its hfq deletion mutant HI2207 (total of approximately
2,000 cfu). Epitympanic taps were performed on all ears on
days 4, 7, 11, and 14 after nontypeable H. influenzae
challenge. Recovered MEE were plated on sBHI and
sBHI containing spectinomycin in order to determine
the total bacterial titer and the titer of the mutant
strain respectively.
Rat model of bacteremia
The infant rat model for hematogeneous meningitis fol-
lowing intraperitoneal infection with H. influenzae [42]
was used to compare the abilities of strains R2866 and
the Δhfq mutant, HI2206, to cause bacteremia.
Again two experiments were performed, one to assess
virulence and a second to assess competitive fitness.
Specified pathogen free (SPF), timed-pregnant Sprague–
Dawley rats (Harlan Sprague–Dawley) were received
approximately five days prior to giving birth. These
pregnant females were single housed on hardwood lit-
ter with ad libitum access to water and a standard
pelleted food (Purina Lab Rodent Diet 5001). They
were maintained on a 12 hour light–dark cycle in sep-
arate forced air cubicles in a bio-containment facility to
prevent cross-contamination. Newborn pups from dif-
ferent mothers were pooled and randomly reassigned
to the mothers (n=10 pups per female).
In the first experiment to assess virulence two groups
of ten 5-day-old infant rats were infected with 100,000 cfu
of either R2866 or the corresponding hfq mutant HI2206
suspended in 100 μl PBS by intraperitoneal injection. Inoc-
ula were prepared as previously described [43]. The dosage
used to infect the rats was confirmed by plate count. Rats
were examined for signs of infection (neurological symp-
toms: tremor, loss of righting ability, coma, rigidity;
systemic symptoms: lethargy, anorexia, hypothermia) at 24-
hour intervals. After placing the animals under anesthesia
(gaseous isoflurane; Butler Animal Health Supply, Dublin,
OH), cardiac puncture was used to obtain blood specimens
on days 1, 2, 3, and 4 post-infection [42].
In the second experiment to assess competitive fitness a
group of ten 5-day old rats was infected by intraperitoneal
injection with a 1:1 mixed culture (WT:Δhfq or Comple-
ment:Δhfq) of 100,000 cfu of each strain in 100 μL PBS.
Rats were examined for clinical signs of infection and
bacteremia as described above in the virulence experiment.
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bacteremia by serially diluting (0 to 10-5) whole-blood
specimens freshly drawn in heparinized syringes with PBS.
Aliquots of 10 μL from each dilution were plated in tripli-
cate on sBHI agar, with or without the appropriate anti-
biotic in the case of the fitness study, and incubated at
least 18 hours at 37°C for quantification.
Ethics statement
All animal studies described herein were performed in
strict accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals (National
Institutes of Health). Animal protocols were reviewed
and approved by the Institutional Animal Care and
Use Committee of the University of Oklahoma Health
Sciences Center.
Statistics
A Mann–Whitney test was performed on all in vitro
growth data over the duration of the experiments using
GraphPad Prism software version 5.0a (GraphPad Soft-
ware, San Diego California USA, www.graphpad.com).
Bacteremic titers from the in vivo studies were analyzed
using a two-tailed Student t-test. A Fisher’s exact test and a
one-sample t-test were performed to compare the com-
petitive index. A P value <0.05 was taken as significant.
Results and discussion
Promoter and sequence analysis of hfq in H. influenzae
Hfq is encoded by the gene HI0411 in the H. influenzae
reference strain Rd KW20 [GenBank: NC_000907] and
consists of 91 amino acids and is at least 97% identical
to Hfq in 20 sequenced strains of H. influenzae. Further-
more, it is 78% similar to the Hfq protein from E. coli
and all residues that contribute to RNA binding in the
latter species are conserved (Figure 1A) [44]. By com-
parison with HI0411, the Hfq protein in E. coli contains
a longer C terminal extension. This C terminal extension
is highly variable among different species of bacteria and
does not contribute to the overall activity of Hfq [45].
The hfq gene is located on the lagging strand of the Rd
KW20 genome and is downstream of the tyrR gene
(encoding a transcriptional regulatory protein) and
upstream of HI0412 (encoding 23S rRNA pseudouridylate
synthase C). These same two genes also flank hfq in
the H. influenzae strains used in the remainder of this
study. The hfq gene is highly conserved among all se-
quenced strains of H. influenzae, an indication that
this gene serves an important function in this species. This
would suggest that H. influenzae also uses Hfq along with
sRNAs to modulate gene expression, the posited role for
Hfq in other prokaryotes.
Nontypeable H. influenzae strains R2866 and 86-028NP
were selected for the studies described herein since bothstrains have each been well characterized both gene-
tically and phenotypically. Both strains have also
been extensively used in the animal models described
herein [22,29,41,46-48]. Rd KW20 was not used for further
study because it is considered an avirulent ‘laboratory
strain’ of H. influenzae since it has lost the genes that en-
code the type d capsule and lacks adhesins that are neces-
sary for nontypeable H. influenzae disease [49,50].
In several organisms the hfq gene is co-transcribed
with the upstream gene miaA when that gene is present
[51,52]. However, in bacterial species in which a gene
other than miaA is upstream, hfq is not co-transcribed
[53]. RT-PCR experiments performed in R2866 and
86-028NP indicated that hfq is not co-transcribed with
either of the flanking genes (data not shown). Primer
extension experiments were performed to identify the
transcription start site and to help determine the location
of the promoter. The major primer restriction product was
123 nt in length (Figure 1B), corresponding to an adenine
transcriptional start site 53 nt upstream of the ATG start
codon (Figure 1C).
Since the sequence of hfq is well conserved in ex-
perimentally relevant strains, hfq deletion mutants
were constructed in order to study the role of Hfq in
H. influenzae. Deletion mutants of the hfq genes of
H. influenzae nontypeable strains R2866 and 86-028NP
were successfully constructed and confirmed by PCR
(data not shown) and were designated HI2206 and HI2207
respectively.
In vitro growth characteristics of H. influenzae hfq
mutants
In other bacterial species, Hfq plays a role in iron regu-
lation and tolerance to various stressors, such as oxida-
tive damage, high salt, and detergents [12,20,54,55].
Since H. influenzae requires heme for aerobic growth,
we conducted growth studies to investigate whether
the deletion of hfq impacted growth and heme source
utilization. Direct comparisons were made between each
wild type strain, and its Δhfq mutant. The complement
strain was also included when studying R2866 and its mu-
tant. Several attempts were made to create a complement
for the 86-028NP Δhfq strain, HI2207, but were unsuccess-
ful. Tested heme sources included free heme, hemoglobin,
hemoglobin-haptoglobin and heme-hemopexin at various
concentrations. The hfq mutants of both strains grew at a
similar rate to the wild type strains in all growth conditions
except under limiting concentrations of hemoglobin
(Figure 2). Complementation of the Δhfq mutation did not
completely restore the wild type phenotype in R2866, but
the complemented strain did grow significantly better than
the Δhfq strain. In vitro competition experiments were
performed in nutrient rich and hemoglobin limiting condi-
tions to determine if competition between the two strains
Figure 1 Characterization of the hfq gene in H. influenzae. (A) CLUSTALW alignment between the Hfq of E. coli (Hfq_Ec) and H. influenzae.
Amino acids denoted by asterisks (*) are identical, colons (:) strongly similar and dots (.) weakly similar. The secondary structure of the E. coli Hfq
is indicated above the sequence and dashed-line boxes denote the Sm1 and Sm2 motifs. The shaded boxes are residues that are important in
RNA binding by the Hfq of S. aureus and the two signature motifs of Hfq are underlined. This was modified from the figure of Nielson et al. [44].
(B) Fluorescent intensities of primer extension products synthesized from H. influenzae RNA. (C) Sequence of the transcription start site (+1) and
the proposed promoter region for the H. influenzae Hfq gene. The sequence complementary to the primer used for primer extension is boxed,
the transcription start site is boldfaced, and the putative −10 and −35 promoter sequences are underlined.
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ference was observed between the two strains under either
growth condition (data not shown). These results suggest
that Hfq may be required for H. influenzae to efficiently
utilize certain nutrients from its environment in order to
occupy specific niches within the host, as seen in other or-
ganisms [18,56]. Previous studies have shown there are two
proteins that are required for the uptake of heme from
hemoglobin, the TonB-dependent Hgps and Hup proteins
[27,57]. However, the expression of these genes is un-
affected by the deletion of hfq (data not shown). Further
studies are needed to understand the potential role of Hfq
in the utilization of heme from hemoglobin.
The ability of the hfq mutant to tolerate other stressful
conditions was also examined. There were no differences
observed in growth between the wild type and mutant
strains in the presence of oxidative stress induced by the
addition of hydrogen peroxide or cumene hydroperox-
ide (data not shown). Thus, no role was detected forH. influenzae Hfq in the regulation of genes involved in
ameliorating oxidative stress as it does in other bacterial
species [12,13]. No significant differences in growth be-
tween wild type and mutant strains were seen in media
containing high salt or sodium dodecyl sulfate (SDS) at
various concentrations (data not shown). In other bacteria
Hfq also plays a role in high salt and detergent stress [21].
These data demonstrate that the phenotypic effects in
H. influenzae strains R2866 and 86-028NP lacking hfq
differ from those observed in other bacterial species [21].
Role of hfq in H. influenzae pathogenesis
The hfq mutants of the nontypeable strains R2866 and
86-028NP were compared for their abilities to establish
and maintain infection in two well established animal
models of human H. influenzae disease. The methods
used for these studies were designed to test for viru-
lence and fitness of the mutant strains in comparison
to their wild type progenitor. The use of different strains
Figure 2 Growth of nontypable H. influenzae strains R2866 and 86-028NP in vitro. (A-C) Growth of R2866 (circles), its isogenic Δhfq mutant
derivative (squares) and the complemented Δhfq mutant (triangles). (D-F) Growth of 86-028NP (circles) and its isogenic Δhfq mutant derivative (squares).
(A & D) Growth in 5 μg mL-1 heme (solid symbols and in hdBHI (open symbols). (B) Growth of R2866 and its derivatives in 10 μg mL-1 hemoglobin.
(C) Growth of R2866 and its derivatives in 5 μg mL-1 hemoglobin. (E) Growth of 86-028NP and its derivative in 30 μg mL-1 hemoglobin. (F) Growth of
86-028NP and its derivative in 20 μg mL-1 hemoglobin. The Mann–Whitney test was used to compare make comparisons between strains over the entire
24-hour growth period. For comparisons of the wild type strains with the corresponding mutant in all concentrations of hemoglobin *P<0.0001.
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H. influenzae generally cannot be used across the different
animal models of disease. In our hands, 86-028NP is un-
able to cause bacteremia in the infant rat model and R2866
infected chinchillas rapidly proceed to inner ear infection
and bacteremia, criteria for termination of the experiment
(unreported observations). Therefore, in order to compare
mutations in multiple animal models, it is necessary to use
different H. influenzae strains.
The nontypeable H. influenzae strain 86-028NP was
compared with the hfq mutant HI2207 in the chinchillamodel of otitis media. Two separate experiments were
performed; a paired comparison assay to determine viru-
lence, and a competition assay to determine fitness defects
in the Δhfq strain. In the virulence assay, two groups of five
animals were challenged with the wild type and mutant
strains, respectively, and assessed on days 4, 7, 11, and 14
post-infection. No differences were observed using video
otoscopy and tympanometry between the two groups in
the progression of otitis media and there were no quali-
tative differences in the middle ear effusions (data not
shown). Furthermore, there was no statistical difference
Figure 3 Deletion of hfq in H. influenzae strain 86-028NP in the chinchilla model of otitis media. (A) Bacterial titers of 86-028NP (closed circles)
and the Δhfq strain HI2207 (closed squares) in the middle ear effusions collected on days 4, 7, 11 and 14 post infection. (B) Competitive index comparing
the input ratios of 86-028NP and HI2207 on day 0 to the output ratios of bacterial titers on the days indicated post infection (**P<0.001).
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the two groups (Figure 3A).
In the fitness assays, five chinchillas were challenged
with the wild type and mutant strains and disease progres-
sion was assessed on days 4, 7, 11, and 14 post-infection
(Figure 3B). Over the duration of the experiment, the wild
type strain produced titers normally seen in otitis media in
the chinchilla following challenge with this strain [46].
However, the mutant strain was unable to compete with
wild type in this environment. The average competitive
index [(mutant output/WT output)/(mutant input/WT
input)] in the ten ears was approximately 0.01 by dayFigure 4 Comparison of H. influenzae strains R2866, HI2206, and HI22
infected with either R2866 (closed circles) or HI2206 (closed squares) in the viru
of bacteria input ratios of R2866 and HI2206 on Day 0 compared to the outpu
comparing the Δhfq strain HI2206 and the complement HI2210. (D) Compariso
independent experiments. (**P<0.0001; *P<0.01).four (P<0.001, one sample t-test for competitive index =
1.0) and continued to decline until day 11 when all ears
were cleared of the mutant strain (Figure 3B). Because
in vitro growth rates of mutant and wild type strains were
not different in sBHI, the results of the mixed challenge
suggest that the mutant’s fitness reduction is specific to the
host environment.
The nontypeable strain R2866 was compared to the hfq
mutant, HI2206, and the Δhfq complement strain, HI2210,
for the ability to establish and maintain bacteremia in the
infant rat model of invasive disease. Virulence and fitness
models of infection were also used in the infant rats. In the10 to sustain bacteremia in infant rats. (A) Bacteremic titers of rats
lence model of infection. (B) Competitive index showing the comparison
t ratios on subsequent days of the infection. (C) Competitive index
n of fitness of R2866 and HI2210. Data are representative of two
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with the wild type or mutant strain and disease progression
was monitored by clinical signs of infection and by bacter-
ial titers in the blood. There was no observed difference in
disease progression between the two groups and there was
no significant difference in the bacterial titers (Figure 4A).
In the infant rat fitness study, two cohorts of 10 pups
were used to compare the fitness of R2866, HI2206, and
HI2210. One group of animals was infected with equal
numbers of R2866 and HI2206 (Figure 4B). The second
group received the complemented strain, HI2210, along
with HI2206 (Figure 4C). The last group of animals was
infected with R2866 and HI2210 (Figure 4D). The hfq
mutant exhibited significantly lower bacteremic titers
throughout the course of the experiment when com-
pared to either the wild type or the complemented mu-
tant strains. As shown by the competitive index, the
Δhfq strain was approximately a 100-fold lower than the
wild type strain by day one and all animals had com-
pletely cleared the mutant strain by day 3 post infection.
Similar differences were observed in the animals infected
with the Δhfq complement strain and the Δhfq strain,
indicating the complement strain exhibits a reversal
of the mutant phenotype, however, there was not a
complete reversal of the mutant phenotype (Figure 4D).
The wild type strain did significantly out compete the
complemented strain on days 2 and 3 post-infection. Com-
plementation only partially restores the in vitro growth
phenotype, and since the in vivo environment is likely to
be more rigorously restricted for essential nutrients, the
difference between wild type and complemented strain
may be exacerbated in vivo.
The role of Hfq during infections of H. influenzae is
not clear. In other organisms several sRNAs that interact
with Hfq have been shown to be important in the regu-
lation of genes involved in pathogenesis [58]. It is cur-
rently unknown if H. influenzae has sRNAs that are
important in pathogenesis. However, our animal studies
suggest that in the absence of Hfq, certain genes import-
ant in establishing infection are likely affected. Presum-
ably, these genes are regulated by sRNAs either directly
or indirectly and require Hfq to function properly. How-
ever, during the virulence studies there was no observed
difference in either animal model, indicating that the
Δhfq mutant was able to grow within the host environ-
ment. The defect is apparently limited to the occupation
of specific niches within the host that are unavailable in
a mixed infection due to the presence of the wild type
strain. The loss of post-transcriptional regulation in the
Δhfq mutant leads to the inability of the bacteria to
adapt to the host environment and compete successfully
for the specific niches that are required for pathogenesis.
The observations made in this study indicate there is
a decrease in fitness in the animal models, and thisphenotype is conserved across different strains. This ef-
fect may be partially explained by the impact of hfq
mutation on acquisition of essential nutrients such as
heme. While we did not address biofilm formation in
the chinchilla middle ear, the possibility remains that
mutation of hfq may influence adherence/biofilm for-
mation in the microenvironment. A better understan-
ding of the nutrients available in the host is necessary
for a comprehensive explanation of the decrease in fit-
ness identified in the mutant strain.
Conclusion
The growth and survival of pathogenic bacteria critically
depends on their ability to monitor environmental changes
within the host organism and adjust their own expression
of stress- and virulence-associated genes accordingly. The
RNA chaperone Hfq is important in modulating genes
essential to stress and virulence in a variety of bacterial
pathogens by binding sRNAs and their mRNA target
[14,51,59]. Our study is the first to report the role of Hfq
in H. influenzae and highlights the impact of Hfq on nutri-
ent acquisition in vitro and infection progression in vivo of
this important human pathogen.
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